Z

Zomedica Corp
AMEX:ZOM

Watchlist Manager
Zomedica Corp
AMEX:ZOM
Watchlist
Price: 0.142693 USD 16.96% Market Closed
Market Cap: 139.8m USD
Have any thoughts about
Zomedica Corp?
Write Note

Zomedica Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zomedica Corp
Cost of Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zomedica Corp
AMEX:ZOM
Cost of Revenue
-$8.2m
CAGR 3-Years
-481%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$11B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.9B
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18.3B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.6B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-14%

See Also

What is Zomedica Corp's Cost of Revenue?
Cost of Revenue
-8.2m USD

Based on the financial report for Jun 30, 2024, Zomedica Corp's Cost of Revenue amounts to -8.2m USD.

What is Zomedica Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-481%

Over the last year, the Cost of Revenue growth was -22%. The average annual Cost of Revenue growth rates for Zomedica Corp have been -481% over the past three years .

Back to Top